sodelglitazar sodelglitazar sodelglitazar, formerly known as gw 677954, is a thiazole pparδ receptor agonist developed by glaxosmithkline. while it is primarily active at the pparδ receptor, it is considered a pan agonist with activity at pparα and pparγ receptors. sodelglitazarclinical datapregnancycategory n/a atc codenonelegal statuslegal status investigational identifiers iupac name -4-methyl-1,3-thiazol-5-yl]methyl]sulfanyl]-2-methylphenoxy]-2-methylpropanoic acid cas number447406-78-2pubchem cid9805950chemspider7981710unii6g973e04vikeggd06647chemblchembl2104984comptox dashboard (epa)dtxsid90196289 chemical and physical dataformulac23h21f4no3s2molar mass499.54 g·mol−13d model (jsmol)interactive image smiles cc1=c(c=cc(=c1)scc2=c(n=c(s2)c3=c(c=c(c=c3)c(f)(f)f)f)c)oc(c)(c)c(=o)o inchi inchi=1s/c23h21f4no3s2/c1-12-9-15(6-8-18(12)31-22(3,4)21(29)30)32-11-19-13(2)28-20(33-19)16-7-5-14(10-17(16)24)23(25,26)27/h5-10h,11h2,1-4h3,(h,29,30)key:zugqwayowcbwgm-uhfffaoysa-n safety phase 2 studies were terminated prior to completion due to safety findings in rodent studies.